Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
The Combination of Anti-PD-1 With Radiotherapy in Previously Untreated Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ATL001 in Patients With Metastatic or Recurrent Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
High Dose IL-2 in Combination With Anti-PD-1
- Status
- TERMINATED
- Phase
- PHASE2
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
- Status
- WITHDRAWN
- Phase
- N/A
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PDR001 + Panobinostat for Melanoma and NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection
- Status
- COMPLETED
- Phase
- PHASE1
Risk Information and Skin-cancer Education for Undergraduate Prevention
- Status
- COMPLETED
- Phase
- NA
A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment
- Status
- TERMINATED
- Phase
- PHASE1
Study of HL-085 in NRAS Mutant Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety Study of SGN-CD47M in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Dietary Intervention in Patients with a History of Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
- Status
- COMPLETED
- Phase
- NA
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
- Status
- COMPLETED
- Phase
- N/A